Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
IX Stock Summary
Top 10 Correlated ETFs
IX
In the News
ORIX Corporation (IX) Q3 2024 Earnings Call Transcript
ORIX Corporation (IX) Q3 2024 Earnings Call Transcript
ORIX Corporation (IX) Q2 2024 Earnings Call Transcript
ORIX Corporation (NYSE:IX ) Q2 2024 Earnings Conference Call November 1, 2023 3:30 AM ET Company Participants Nakane – Investor Relations Sustainability Promotion Division Hitomaro Yano – Executive Officer-Accounting and Treasury and Investor Relations Makoto Inoue – President and Chief Executive Officer Conference Call Participants Masao Muraki – SMBC Nikko Securities Koki Sato – JPMorgan Securities Kazuki Watanabe – Daiwa Securities Natsumu Tsujino – Mitsubishi UFJ Morgan Stanley Securities Taiki Okada – UBS Koichi Niwa – Citigroup Global Markets Nakane Now it's time to start the ORIX Corporation's Financial Results Briefing for the Six-Month Period Ended September 30, 2023. Thank you very much for joining us today.
ORIX: Spotlight On Share Repurchases And Asset Monetization
ORIX Corporation has already completed more than half of its current fiscal 2024 JPY50 billion share repurchase program by end-Aug. IX plans to divest some of its domestic logistics properties and overseas renewable energy plants in this fiscal year. I leave my Buy rating for ORIX Corporation unchanged, as IX could trade at a higher valuation multiple with accretive capital allocation moves such as asset divestments and share repurchases.
ORIX Corporation (IX) Q1 2024 Earnings Call Transcript
ORIX Corporation (NYSE:IX ) Q1 2024 Earnings Call Transcript August 4, 2023 3:30 AM ET Company Participants Hitomaro Yano - Executive Officer for Accounting and IR Conference Call Participants Kazuki Watanabe - Daiwa Securities Masao Muraki - SMBC Nikko Securities NatsumuTsujino Mitsubishi - UFJ Morgan Stanley Futoshi Sasaki - Nomura Securities Koki Sato - JPMorgan Taiki Okada - UBS Securities Koichi Niwa - Citigroup Naruhiko Sakamaki - Mizuho Securities Operator So it is now time to get started. Thank you for joining us for the First Quarter Consolidated Financial Results for the three-month period ended June 30, 2023.
ORIX Corporation (IX) Q4 2023 Earnings Call Transcript
ORIX Corporation (NYSE:IX ) Q4 2023 Results Conference Call May 10, 2023 3:30 AM ET Company Participants Makoto Inoue - President, Executive Officer and Chief Executive Officer Hitomaro Yano - Executive Officer for Accounting and IR Conference Call Participants Kazuki Watanabe - Daiwa Securities Masao Muraki - SMBC Nikko Securities NatsumuTsujino Mitsubishi - UFJ Morgan Stanley Taiki Okada - UBS Securities Koki Sato - JPMorgan Koichi Niwa - Citigroup Securities Operator Good evening, ladies and gentlemen. Thank you for joining this telephone conference by ORIX Corporation for Consolidated Financial Results for the Fiscal Year Ended March 31, 2023.
7 Reliable Dividend Stocks With Low-Payout Ratios
While it's always good to have decent exposure to investments yielding passive income, you also want to consider reliable dividend stocks with low-payout ratios. By that, I'm referring to enterprises that pay their dividends via a relatively small pool of their earnings.
IX or BX: Which Is the Better Value Stock Right Now?
IX vs. BX: Which Stock Is the Better Value Option?
IX vs. BX: Which Stock Is the Better Value Option?
IX vs. BX: Which Stock Is the Better Value Option?
Should Value Investors Buy Orix Corp Ads (IX) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
IX or BX: Which Is the Better Value Stock Right Now?
IX vs. BX: Which Stock Is the Better Value Option?
IX Financial details
IX Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 5.06K | 5.22K | 5.75K | 6.54K | 6.92K | |
Net income per share | 1.26K | 1.19K | 777.69 | 1.3K | 1.16K | |
Operating cash flow per share | 2.3K | 4.09K | 4.46K | 4.58K | 3.87K | |
Free cash flow per share | -1.85K | 194.31 | 1.38K | 773.08 | -707.35 | |
Cash per share | 6.68K | 10.25K | 11.95K | 13K | 14.68K | |
Book value per share | 11.32K | 11.74K | 12.24K | 13.55K | 14.22K | |
Tangible book value per share | 9.85K | 10.28K | 10.54K | 11.98K | 11.86K | |
Share holders equity per share | 11.32K | 11.74K | 12.24K | 13.55K | 14.22K | |
Interest debt per share | 17.93K | 18.49K | 19.41K | 20.5K | 24.76K | |
Market cap | 2077.1B | 1615.15B | 2319.66B | 2945.02B | 2581B | |
Enterprise value | 5411.84B | 5248.67B | 6092.52B | 6856.88B | 7067.66B | |
P/E ratio | 6.42 | 5.34 | 12.06 | 9.44 | 9.45 | |
Price to sales ratio | 1.6 | 1.21 | 1.63 | 1.87 | 1.58 | |
POCF ratio | 3.53 | 1.55 | 2.1 | 2.67 | 2.83 | |
PFCF ratio | -4.39 | 32.59 | 6.79 | 15.83 | -15.46 | |
P/B Ratio | 0.72 | 0.54 | 0.77 | 0.9 | 0.77 | |
PTB ratio | 0.72 | 0.54 | 0.77 | 0.9 | 0.77 | |
EV to sales | 4.17 | 3.94 | 4.29 | 4.35 | 4.33 | |
Enterprise value over EBITDA | 7.87 | 7.36 | 10.17 | 8.26 | 9.9 | |
EV to operating cash flow | 9.21 | 5.03 | 5.53 | 6.21 | 7.74 | |
EV to free cash flow | -11.45 | 105.92 | 17.83 | 36.85 | -42.32 | |
Earnings yield | 0.16 | 0.19 | 0.08 | 0.11 | 0.11 | |
Free cash flow yield | -0.23 | 0.03 | 0.15 | 0.06 | -0.06 | |
Debt to equity | 1.55 | 1.54 | 1.56 | 1.49 | 1.7 | |
Debt to assets | 0.37 | 0.35 | 0.35 | 0.34 | 0.37 | |
Net debt to EBITDA | 4.85 | 5.1 | 6.3 | 4.71 | 6.28 | |
Current ratio | 2.44 | 6.42 | 7.69 | 6.26 | 5.75 | |
Interest coverage | 4.2 | 4.12 | 3.63 | 7.32 | 2.83 | |
Income quality | 1.8 | 3.4 | 5.6 | 3.47 | 3.26 | |
Dividend Yield | 0.04 | 0.06 | 0.04 | 0.03 | 0.04 | |
Payout ratio | 0.27 | 0.34 | 0.49 | 0.32 | 0.39 | |
Sales general and administrative to revenue | 0.66 | 0.7 | 0.74 | 0.72 | 0.73 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.04 | 0.03 | 0.04 | 0.03 | 0.04 | |
Capex to operating cash flow | -1.8 | -0.95 | -0.69 | -0.83 | -1.18 | |
Capex to revenue | -0.82 | -0.75 | -0.54 | -0.58 | -0.66 | |
Capex to depreciation | -3.59 | -3.26 | -2.41 | -2.78 | -3.06 | |
Stock based compensation to revenue | 0.03 | -0.01 | -0.02 | -0.01 | -0.02 | |
Graham number | 17.94K | 17.71K | 14.64K | 19.88K | 19.24K | |
ROIC | 0.04 | 0.04 | 0.02 | 0.04 | 0.03 | |
Return on tangible assets | 0.03 | 0.02 | 0.01 | 0.02 | 0.02 | |
Graham Net | -28.2K | -24.71K | -25.77K | -27.48K | -30.12K | |
Working capital | 870.52B | 3356.55B | 3798.98B | 3847.3B | 4161.73B | |
Tangible asset value | 2522.52B | 2622.02B | 2607.87B | 2882.55B | 2799.62B | |
Net current asset value | 7748.17B | 6025.59B | 6092.98B | 6320.91B | 6801.52B | |
Invested capital | 1.55 | 1.54 | 1.56 | 1.49 | 1.7 | |
Average receivables | 303.64B | 837.38B | 1387.03B | 1430.22B | 1509.78B | |
Average payables | 277.89B | 288.1B | 271.72B | 276.07B | 329.14B | |
Average inventory | 57.85B | 120.85B | 134.08B | 140.86B | 154.29B | |
Days sales outstanding | 87.98 | 373.49 | 362.45 | 335.68 | 350.95 | |
Days payables outstanding | 69.01 | 73.47 | 64.95 | 67.51 | 81.23 | |
Days of inventory on hand | 27.2 | 32.74 | 35.41 | 32.33 | 37.43 | |
Receivables turnover | 4.15 | 0.98 | 1.01 | 1.09 | 1.04 | |
Payables turnover | 5.29 | 4.97 | 5.62 | 5.41 | 4.49 | |
Inventory turnover | 13.42 | 11.15 | 10.31 | 11.29 | 9.75 | |
ROE | 0.11 | 0.1 | 0.06 | 0.1 | 0.08 | |
Capex per share | -4.14K | -3.89K | -3.08K | -3.81K | -4.58K |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.69K | 1.8K | 1.89K | 1.87K | 1.84K | |
Net income per share | 381.52 | 262.24 | 269.34 | 280.25 | 394.57 | |
Operating cash flow per share | 1.35K | 1.42K | 842.23 | 1.7K | 1.45K | |
Free cash flow per share | 76.03 | 128.71 | -531.85 | 248.07 | 1.37K | |
Cash per share | 13.02K | 14.74K | 14.24K | 13.91K | 7.1K | |
Book value per share | 13.86K | 14.27K | 15.58K | 16.18K | 16.14K | |
Tangible book value per share | 12.1K | 11.9K | 13.12K | 13.69K | 13.71K | |
Share holders equity per share | 13.86K | 14.27K | 15.58K | 16.18K | 16.14K | |
Interest debt per share | 22.32K | 24.48K | 25.21K | 26.17K | 26.11K | |
Market cap | 2470.1B | 2571.86B | 3087.19B | 3269.64B | 3039.41B | |
Enterprise value | 6724.21B | 7058.52B | 8016.18B | 8389.16B | 8115.74B | |
P/E ratio | 6.89 | 10.42 | 12.26 | 12.55 | 8.34 | |
Price to sales ratio | 6.21 | 6.09 | 6.99 | 7.52 | 7.16 | |
POCF ratio | 7.8 | 7.71 | 15.68 | 8.3 | 9.06 | |
PFCF ratio | 138.33 | 84.94 | -24.83 | 56.71 | 9.6 | |
P/B Ratio | 0.76 | 0.77 | 0.85 | 0.87 | 0.82 | |
PTB ratio | 0.76 | 0.77 | 0.85 | 0.87 | 0.82 | |
EV to sales | 16.89 | 16.71 | 18.14 | 19.29 | 19.12 | |
Enterprise value over EBITDA | 30.9 | 40.24 | 46.18 | 44.9 | 62.59 | |
EV to operating cash flow | 21.23 | 21.17 | 40.71 | 21.29 | 24.2 | |
EV to free cash flow | 376.56 | 233.12 | -64.47 | 145.51 | 25.63 | |
Earnings yield | 0.04 | 0.02 | 0.02 | 0.02 | 0.03 | |
Free cash flow yield | 0.01 | 0.01 | -0.04 | 0.02 | 0.1 | |
Debt to equity | 1.6 | 1.7 | 1.61 | 1.6 | 1.6 | |
Debt to assets | 0.36 | 0.37 | 0.38 | 0.38 | 0.38 | |
Net debt to EBITDA | 19.55 | 25.58 | 28.39 | 27.4 | 39.15 | |
Current ratio | 6.46 | 5.75 | 5.49 | 5.21 | 2.5 | |
Interest coverage | 3.17 | 2.11 | 2.05 | 1.96 | 2.72 | |
Income quality | 3.5 | 5.29 | 3.07 | 5.93 | 3.68 | |
Dividend Yield | 0.02 | 0 | 0.02 | 0 | 0.02 | |
Payout ratio | 0.56 | 0 | 0.8 | 0 | 0.55 | |
Sales general and administrative to revenue | 0.68 | 0.75 | 0.74 | 0.73 | 0.9 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | |
Capex to operating cash flow | -0.94 | -0.91 | -1.63 | -0.85 | -0.06 | |
Capex to revenue | -0.75 | -0.72 | -0.73 | -0.77 | -0.04 | |
Capex to depreciation | -2.99 | -3.26 | -3.76 | -3.61 | -0.2 | |
Stock based compensation to revenue | 0 | -0.07 | 0 | 0 | 0 | |
Graham number | 10.91K | 9.18K | 9.72K | 10.1K | 11.97K | |
ROIC | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Return on tangible assets | 0.01 | 0 | 0 | 0 | 0.01 | |
Graham Net | -29.7K | -30.22K | -31.15K | -32.07K | -39.22K | |
Working capital | 3811.68B | 4161.73B | 3993.66B | 3856.77B | 1465.97B | |
Tangible asset value | 2841.97B | 2799.62B | 3067.67B | 3182.67B | 3165.51B | |
Net current asset value | 6685.68B | 6801.52B | 6978.1B | 7180.23B | 9520.75B | |
Invested capital | 1.6 | 1.7 | 1.61 | 1.6 | 1.6 | |
Average receivables | 1445.66B | 1511.19B | 1563.11B | 1547.44B | 1539.35B | |
Average payables | 250.64B | 309.81B | 340.92B | 322.42B | 330.2B | |
Average inventory | 150.24B | 157.47B | 169.52B | 196.46B | 227.05B | |
Days sales outstanding | 328.16 | 334.69 | 316.75 | 318.58 | 326.3 | |
Days payables outstanding | 65.18 | 80.98 | 70.97 | 74.98 | 79.08 | |
Days of inventory on hand | 37.63 | 37.31 | 38.31 | 50.67 | 55.31 | |
Receivables turnover | 0.27 | 0.27 | 0.28 | 0.28 | 0.28 | |
Payables turnover | 1.38 | 1.11 | 1.27 | 1.2 | 1.14 | |
Inventory turnover | 2.39 | 2.41 | 2.35 | 1.78 | 1.63 | |
ROE | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | |
Capex per share | -1.27K | -1.29K | -1.37K | -1.45K | -80.88 |
IX Frequently Asked Questions
What is ORIX Corporation stock symbol ?
ORIX Corporation is a JP stock and trading under the symbol IX
What is ORIX Corporation stock quote today ?
ORIX Corporation stock price is $110.2 today.
Is ORIX Corporation stock public?
Yes, ORIX Corporation is a publicly traded company.